Neutrophil to lymphocyte ratio (NLR) as an indicator of tumor immune status in non-small cell lung cancer

被引：0
|
作者：
Yoshichika, Ryo
Iwata, Kazuma
Suzawa, Ken
Thu, Yin Min
Mizuno, Daisuke
Higashihara, Tomoaki
Hayashi, Naohiro
Matsuoka, Atsushi
Yoshikawa, Mao
Mukohara, Fumiaki
Shien, Kazuhiko
Yamamoto, Hiromasa
Toyooka, Shinichi
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-7667
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7667
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study
    Alessandro Russo
    Marco Russano
    Tindara Franchina
    Maria R. Migliorino
    Giuseppe Aprile
    Giovanni Mansueto
    Alfredo Berruti
    Alfredo Falcone
    Michele Aieta
    Alain Gelibter
    Antonio Russo
    Sandro Barni
    Michele Maio
    Olga Martelli
    Francesco Pantano
    Daniela Iacono
    Lorenzo Calvetti
    Silvia Quadrini
    Elisa Roca
    Enrico Vasile
    Marco Imperatori
    Mario Occhipinti
    Antonio Galvano
    Fausto Petrelli
    Luana Calabrò
    Giulia Pasquini
    Salvatore Intagliata
    Giuseppina R. R. Ricciardi
    Giuseppe Tonini
    Daniele Santini
    Vincenzo Adamo
    Advances in Therapy, 2020, 37 : 1145 - 1155
  • [32] Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study
    Russo, Alessandro
    Russano, Marco
    Franchina, Tindara
    Migliorino, Maria R.
    Aprile, Giuseppe
    Mansueto, Giovanni
    Berruti, Alfredo
    Falcone, Alfredo
    Aieta, Michele
    Gelibter, Alain
    Russo, Antonio
    Barni, Sandro
    Maio, Michele
    Martelli, Olga
    Pantano, Francesco
    Iacono, Daniela
    Calvetti, Lorenzo
    Quadrini, Silvia
    Roca, Elisa
    Vasile, Enrico
    Imperatori, Marco
    Occhipinti, Mario
    Galvano, Antonio
    Petrelli, Fausto
    Calabro, Luana
    Pasquini, Giulia
    Intagliata, Salvatore
    Ricciardi, Giuseppina R. R.
    Tonini, Giuseppe
    Santini, Daniele
    Adamo, Vincenzo
    ADVANCES IN THERAPY, 2020, 37 (03) : 1145 - 1155
  • [33] Predictability of early changes in derived neutrophil-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors
    Lim, Jeong Uk
    Kang, Hye Seon
    Yeo, Chang Dong
    Kim, Ju Sang
    Park, Chan Kwon
    Kim, Jin Woo
    Kim, Seung Joon
    Lee, Sang Haak
    JOURNAL OF THORACIC DISEASE, 2021, 13 (05) : 2824 - 2832
  • [34] Neutrophil to lymphocyte ratio (NLR) as a useful prognostic marker for survival in patients with locally advanced (stage III) non-small cell lung cancer (NSCLC).
    Tahir, Ali
    Hopman, Wilma M.
    Robinson, Andrew George
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [35] Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients
    Wu, Guannan
    Yao, Yanwen
    Bai, Cuiqing
    Zeng, Junli
    Shi, Donghong
    Gu, Xiaoling
    Shi, Xuefei
    Song, Yong
    THORACIC CANCER, 2015, 6 (03) : 275 - 287
  • [36] Prognostic impact of neutrophil-to-lymphocyte ratio (NLR) pre and post chemoradiotherapy (CRT) in stage III non-small cell lung cancer (NSCLC)
    Palomar Abril, V.
    Soria-Comes, T.
    Martin Ureste, M.
    Maestu Maiques, I.
    ANNALS OF ONCOLOGY, 2019, 30
  • [37] Dynamic changes of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lactate dehydrogenase (LDH) during treatment with immune checkpoint inhibitors (ICIs) in non-small cell lung cancer (NSCLC).
    Russo, Alessandro
    Franchina, Tindara
    Ricciardi, Giuseppina
    Battaglia, Alessandra
    Schifano, Silvia
    Schifilliti, Maurizio
    Scimone, Antonino
    Toscano, Giuseppe
    Zanghi, Mariangela
    Adamo, Vincenzo
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [38] Pretreatment Neutrophit-to-Lymphocyte Ratio (NLR) Predicts Outcomes with Nivolumab in Non-Small Cell Lung Cancer (NSCLC)
    Bagley, Stephen
    Kothari, Shawn
    Aggarwal, Charu
    Bauml, Joshua
    Alley, Evan
    Evans, Tracey
    Kosteva, John
    Ciunci, Christine
    Thompson, Jeffrey
    Stonehouse-Lee, Susan
    Sherry, Victoria
    Gilbert, Elizabeth
    Eaby-Sandy, Beth
    Mutale, Faith
    Dilullo, Gloria
    Cohen, Roger
    Vachani, Anil
    Langer, Corey
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1318 - S1318
  • [39] Preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are correlated with tumor-node-metastasis stages in patients with non-small cell lung cancer
    Cheng, Han
    Bhushan, Sandeep
    Li, Na
    Xiao, Zongwei
    Gao, Ke
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (06) : 1666 - 1673
  • [40] High Blood Neutrophil-to-lymphocyte Ratio as an Indicator of Poor Prognosis In Advanced Non Small Cell Lung Cancer
    Torrejon Castro, D.
    Cedres, S.
    Argiles, G.
    Nunez, I.
    Rodriguez-Freixinos, V.
    Mulet, N.
    Lara, M.
    Martinez, P.
    Tabernero, J.
    Felip, E.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S182 - S182
12345